Currently, 18 generic manufacturers (17 sublicensees under the MPP and Aurobindo
Pharma via a separate direct voluntary licence agreement with ViiV Healthcare) are authorised to produce and sell low-cost single or fixed-dose combination versions of DTG all least developed, low-income, lower-middle income, and sub-Saharan Africa countries as well as some other upper middle-income countries (paediatric licence only), totalling 94 and 121 countries for the adult and paediatric agreements respectively., These licensing agreements have also allowed generic manufacturers to include dolutegravir in a newly developed fixed-dose combination, tenofovir disoproxil fumarate/ lamivudine/dolutegravir (TLD), which combines the WHO-preferred treatment regimen into a single pill.
Summary: Hyderabad, Feb 11 (ANI): Aurobindo
Pharma, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, on Monday announced that it has closed the acquisition of ApotexaACAOs commercial operations and certain supporting infrastructure in five European countries.
Acrotech Biopharma, a subsidiary of Aurobindo
Pharma, has agreed to acquire seven FDA-approved haematology/oncology products from Spectrum Pharmaceuticals, it was reported on Friday.
Spectrum Pharmaceuticals announced that it has entered into a definitive agreement to sell its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma, Acrotech Biopharma is a New Jersey-based wholly-owned subsidiary of Aurobindo
India-based pharmaceutical manufacturer Aurobindo
said, 'Really speaking, fear is in the vital being.
The Tagore family immediately comes to mind, but it is another kind of modernity, embodied by Aurobindo
Ghose, that led to the foundation of Auroville.
AIMING to ease out traffic pressure on South Delhi's one of the most congested stretches of Aurobindo
Marg, the Delhi traffic department has identified 23 trees that are creating hurdles in smooth commuting.
Pharma, a producer of APIs and formulations, is a great example.
New Delhi: Aurobindo
Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.
Forty five year old female was admitted in the surgical ward of Sri Aurobindo
Medical College and Postgraduate Institute with complaints of a reducible swelling in the paraumblical region with mild pain.